Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB110-40730 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB110-40730, RRID:AB_2064243
- Product name
- Rabbit Polyclonal BIRC6 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 ml
- Storage
- Store at 4C. Do not freeze.
Submitted references Baculoviral IAP Repeat Containing 6 (BIRC6) Is a Predictor of Prognosis in Prostate Cancer.
BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer.
The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.
BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cells.
Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Zhuang W, Zhang C, Hao F, Sun X
Medical science monitor : international medical journal of experimental and clinical research 2018 Feb 10;24:839-845
Medical science monitor : international medical journal of experimental and clinical research 2018 Feb 10;24:839-845
BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer.
Luk IS, Shrestha R, Xue H, Wang Y, Zhang F, Lin D, Haegert A, Wu R, Dong X, Collins CC, Zoubeidi A, Gleave ME, Gout PW, Wang Y
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Mar 15;23(6):1542-1551
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Mar 15;23(6):1542-1551
The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.
Luk SU, Xue H, Cheng H, Lin D, Gout PW, Fazli L, Collins CC, Gleave ME, Wang Y
Oncotarget 2014 Aug 30;5(16):6896-908
Oncotarget 2014 Aug 30;5(16):6896-908
BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cells.
Low CG, Luk IS, Lin D, Fazli L, Yang K, Xu Y, Gleave M, Gout PW, Wang Y
PloS one 2013;8(2):e55837
PloS one 2013;8(2):e55837
Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013 Feb;8(2):161-70
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013 Feb;8(2):161-70
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: BIRC6 Antibody [NB110-40730] - FFPE section of human metastatic lymph node. Antibody: Affinity purified rabbit anti-BIRC6/Apollon used at a dilution of 1:250. Detection: DAB
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: BIRC6 Antibody [NB110-40730] - FFPE section of human ovarian tumor. Antibody: Affinity purified rabbit antiBIRC6/Apollon used at a dilution of 1:250. Detection: DAB
